PPrivate Fund Data
CompaniesFundsPeopleRankingsScreener

Abingworth Clinical Co-Development Fund 3

Private Equity FundFund ID 805-6484309553Delaware, United States
Gross assets
$65.9M
Min. investment
$10M
Beneficial owners
97
Size rank
Top 51%
Audited
Yes
Structure
Master

About this fund

Abingworth Clinical Co-Development Fund 3 is a private equity fund managed by Carlyle Investment Management L.L.C.. The fund reports $65.9 million in gross assets, placing it among the top 51% of private funds by size. The stated minimum investment is $10 million. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.

Fund details

Fund ID805-6484309553
Fund typePrivate Equity Fund
3(c)(1) exclusionNo
3(c)(7) exclusionYes
Master fundYes
Feeder fundNo
Fund of fundsNo
Relies on exemption from registrationYes
Annual auditYes
Prepared per GAAPYes
Sub-advisedNo
% of assets independently valued0%

Other funds from this manager

FundTypeGross assets
Carlyle Partners VIIPrivate Equity$22.22B
Carlyle Partners VIIIPrivate Equity$14.33B
Carlyle Realty Partners IXReal Estate$7.34B
See all 313 funds from this manager — unlock the full record.
Join to unlock · $37/mo

Frequently asked questions

How large is Abingworth Clinical Co-Development Fund 3?

Abingworth Clinical Co-Development Fund 3 reports $65.9 million in gross assets, among the top 51% of private funds by size.

What is the minimum investment for Abingworth Clinical Co-Development Fund 3?

The stated minimum investment is $10 million.

Who manages Abingworth Clinical Co-Development Fund 3?

Abingworth Clinical Co-Development Fund 3 is managed by Carlyle Investment Management L.L.C.

Does Abingworth Clinical Co-Development Fund 3 disclose returns?

No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.

Service providers

Prime broker
None reported
Marketer

Reported gross assets

$65.9MNo change
Mar '26 — $65.9MApr '26 — $65.9MMay '26 — $65.9MJun '26 — $65.9M
Mar '26Form ADV, monthlyJun '26

How this fund compares

Gross assetsTop 51%
Larger than 49% of 67,041 private funds
Gross assets vs Private Equity FundsTop 48%
Larger than 52% of 31,066 private equity funds
Minimum investmentTop 6%
Higher than 94% of funds reporting a minimum

Investor base

Adviser & related persons5%
Funds of funds1%
Non-U.S. persons3%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.